Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus

NCT01868594 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT01868594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01868594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus
Lead sponsor
Materia Medica Holding
Phase
Phase 4
Overall status
Completed
Start date
May 7, 2013
Completion date
July 10, 2016
Enrollment
200 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

type i diabetes mellitus